FDA approval is NOT going to be the driver of higher share price. Partnership, or lack thereof, is what will drive the share price.
After approval comes on Thursday, I suspect the price will drop if there is no additional news provided by the company. The price will drop only because many will be disappointed that they didn't get their erroneously anticipated 50% bump in share price. Announcement of a partnership on Thursday? Disregard the above! <G> Unfortunately, I don't look for a partnership announcement on Thursday. I hope I'm wrong.